Global S-Amlodipine Supply, Demand and Key Producers, 2023-2029

Global S-Amlodipine Supply, Demand and Key Producers, 2023-2029

The global S-Amlodipine market size is expected to reach $ 75160 million by 2029, rising at a market growth of 10.8% CAGR during the forecast period (2023-2029).

Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.

S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).

This report studies the global S-Amlodipine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for S-Amlodipine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of S-Amlodipine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global S-Amlodipine total production and demand, 2018-2029, (K Units)

Global S-Amlodipine total production value, 2018-2029, (USD Million)

Global S-Amlodipine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global S-Amlodipine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: S-Amlodipine domestic production, consumption, key domestic manufacturers and share

Global S-Amlodipine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global S-Amlodipine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global S-Amlodipine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global S-Amlodipine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aristo Pharmaceuticals Pvt Ltd, Novartis, Pfizer, Lek, TEVA, Macleods Pharmaceuticals, Caraco Pharmaceutical, Sanis Health and Jamp Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World S-Amlodipine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global S-Amlodipine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global S-Amlodipine Market, Segmentation by Type
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets

Global S-Amlodipine Market, Segmentation by Application
Hypertension
Angina pectoris

Companies Profiled:
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical

Key Questions Answered

1. How big is the global S-Amlodipine market?

2. What is the demand of the global S-Amlodipine market?

3. What is the year over year growth of the global S-Amlodipine market?

4. What is the production and production value of the global S-Amlodipine market?

5. Who are the key producers in the global S-Amlodipine market?

6. What are the growth factors driving the market demand?